Computational prediction of MHC anchor locations guides neoantigen identification and prioritization.
Ontology highlight
ABSTRACT: Neoantigens are tumor-specific peptide sequences resulting from sources such as somatic DNA mutations. Upon loading onto major histocompatibility complex (MHC) molecules, they can trigger recognition by T cells. Accurate neoantigen identification is thus critical for both designing cancer vaccines and predicting response to immunotherapies. Neoantigen identification and prioritization relies on correctly predicting whether the presenting peptide sequence can successfully induce an immune response. Because most somatic mutations are single-nucleotide variants, changes between wild-type and mutated peptides are typically subtle and require cautious interpretation. A potentially underappreciated variable in neoantigen prediction pipelines is the mutation position within the peptide relative t
SUBMITTER: Xia H
PROVIDER: S-EPMC10450883 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA